Phase 2 · Family

One device. The whole household.

A shared immunological view for families, with granular privacy controls for every member.

A family at home

What the data shows

1 device
Whole household
Per-person
Baselines
You decide
What's shared

The problem

Families share a home, not a baseline.

01

Children, parents and grandparents have wildly different immune profiles, and they change at different speeds.

02

When something goes around the household, it's hard to tell early who is actually mounting a response.

03

Shared-account health apps either over-share or under-share, there is no real consent model.

One Proxima, many profiles.

Shared device

One Proxima, many profiles.

Each household member has their own cartridge code and their own private baseline. The device is shared; the data is not.

See what's worth seeing.

Caregiver view

See what's worth seeing.

Parents can opt in to age-appropriate views of children's trends; adult children can be granted visibility into a parent's results, with explicit consent.

How we handle data
At home, for everyone.

Built for the home

At home, for everyone.

A single Proxima case lives on a shelf. Each user scans their own cartridge and runs a test in under 20 minutes; results go to that person's own account.

Meet Algocyte Proxima

A household routine.

01

One device

Proxima lives in the kitchen or hallway, ready to use.

02

Personal cartridge

Each person's cartridge is paired to their own account.

03

Private results

Trends are visible only to the people you choose.

04

Family signal

Optional household view for caregivers and shared decisions.

Built for:

Bring regular immune monitoring to users and patients.

Book a 20-minute briefing with our team to see Algocyte in action.